ATIII Antibodies

Santa Cruz Biotechnology features a diverse variety of ATIII Antibodies for research focused on understanding antithrombin III (ATIII) in various biological processes. ATIII Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Antithrombin III is a critical plasma protein that functions as a key regulator of blood coagulation by inhibiting thrombin and other serine proteases. ATIII plays an essential role in maintaining hemostatic balance, making it a significant focus in studies related to thrombosis, cardiovascular diseases, and various hematological disorders. Research into ATIII mechanisms continues to advance understanding of clotting disorders and potential therapeutic interventions. Investigating ATIII expression patterns and interactions helps reveal its regulatory functions in different physiological states. Advanced research techniques enable detailed analysis of ATIII's role in both normal and pathological conditions. Exploring ATIII's involvement in coagulation cascades provides valuable insights for developing new treatment approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of antithrombin III and its impact on human health.